Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4266]

SABCS 2019: Breast-conserving treatment without surgery not supported at this time

SABCS 2019: Breast-conserving treatment without surgery not supported at this time

SABCS 2019: Patient-reported outcomes predict aromatase inhibitor adherence

SABCS 2019: Patient-reported outcomes predict aromatase inhibitor adherence

SABCS 2019: Predicting triple negative breast cancer recurrence

SABCS 2019: Predicting triple negative breast cancer recurrence

SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breast cancer patients in phase III trial

SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breast cancer...

SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type

SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type

SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestin have opposite effects on breast cancer incidence in postmenopausal women

SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestin have opposite effects on breast...

SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer

SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer

Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive breast cancer

SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive...

SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated with tamoxifen alone

SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated with tamoxifen...

More from ecancer